Trial intelligence / Profile preview

Evaluation of progesterone-related compounds for the tertiary prophylaxis of preterm delivery

2009-017441-63Phase 4Active

Sponsor
U.O. Ginecologia e Ostetricia
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Preterm labor (PTL) and preterm birth prevention comparing Progesterone with Hydroxyprogesterone caproate (17P) (2 arms). Primary endpoint: Delivery before 37 weeks. Started Mar 2010; status: active.

02

Drugs

progesteronehydroxyprogesterone caproate
03

Conditions

Preterm labor (PTL)preterm birth prevention

Beyond the preview

Go deeper on 2009-017441-63.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017441-63.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call